Zhejiang Orient Gene Biotech Co., Ltd. (688298.SS)
CNY 29.1
(-2.68%)
CNY 29.1
(-2.68%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 696.95 Million CNY | 747.92% |
| 2022 | 82.19 Million CNY | 344.57% |
| 2021 | 18.48 Million CNY | 254.36% |
| 2020 | 5.21 Million CNY | -80.68% |
| 2019 | 27 Million CNY | -45.99% |
| 2018 | 50 Million CNY | -10.71% |
| 2017 | 56 Million CNY | -26.32% |
| 2016 | 76 Million CNY | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 625.75 Million CNY | -10.22% |
| 2024 Q2 | 616.52 Million CNY | -1.47% |
| 2024 Q3 | 186.73 Million CNY | -61.09% |
| 2023 Q1 | 625.14 Million CNY | 660.54% |
| 2023 FY | 696.95 Million CNY | 747.92% |
| 2023 Q4 | 696.95 Million CNY | 20.24% |
| 2023 Q3 | 579.62 Million CNY | -0.22% |
| 2023 Q2 | 580.91 Million CNY | -7.07% |
| 2022 Q2 | 34.81 Million CNY | 35.05% |
| 2022 Q1 | 25.78 Million CNY | 39.43% |
| 2022 FY | 82.19 Million CNY | 344.57% |
| 2022 Q4 | 82.19 Million CNY | 0.88% |
| 2022 Q3 | 81.47 Million CNY | 134.03% |
| 2021 Q1 | - CNY | 0.0% |
| 2021 FY | 18.48 Million CNY | 254.36% |
| 2021 Q2 | 17.8 Million CNY | 0.0% |
| 2021 Q3 | 20.74 Million CNY | 16.56% |
| 2021 Q4 | 18.48 Million CNY | -10.89% |
| 2020 Q4 | - CNY | 0.0% |
| 2020 FY | 5.21 Million CNY | -80.68% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 Q2 | - CNY | -100.0% |
| 2020 Q1 | 6.65 Million CNY | -75.35% |
| 2019 Q3 | 20.4 Million CNY | -59.67% |
| 2019 Q4 | 27 Million CNY | 32.32% |
| 2019 Q2 | 50.6 Million CNY | 0.0% |
| 2019 Q1 | - CNY | -100.0% |
| 2019 FY | 27 Million CNY | -45.99% |
| 2018 FY | 50 Million CNY | -10.71% |
| 2018 Q4 | 50 Million CNY | 0.0% |
| 2017 FY | 56 Million CNY | -26.32% |
| 2016 FY | 76 Million CNY | 0.0% |